Italian Observational Study on CAR-T Therapy for Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5
- Status
- RECRUITING
- Phase
- PHASE3
Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
- Status
- RECRUITING
- Phase
- PHASE2
Relmacabtagene Autoleucel in Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Status
- RECRUITING
- Phase
- N/A
Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance
- Status
- RECRUITING
- Phase
- N/A
A Study to Assess Efficacy and Safety of Oral Tazemetostat in Adult Participants With Relapsed/Refractory Follicular Lymphoma That Does Not Have an "EZH2 Gain-of-function" Genetic Mutation
- Status
- WITHDRAWN
- Phase
- PHASE2
Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Status
- RECRUITING
- Phase
- PHASE1
Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)
- Status
- COMPLETED
- Phase
- NA
Tazemetostat and Mosunetuzumab in Untreated Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
- Status
- RECRUITING
- Phase
- PHASE3